Carbenoxolone topical - York Pharma

Drug Profile

Carbenoxolone topical - York Pharma

Alternative Names: Carbenoxolone gel - York Pharma; Carbenoxolone sodium; Vampex; YP 003

Latest Information Update: 01 Apr 2011

Price : $50

At a glance

  • Originator York Pharma
  • Class Antiulcers; Cytoprotectives; Triterpenes
  • Mechanism of Action Retinoic acid metabolism modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Psoriasis

Most Recent Events

  • 08 Feb 2006 Data from a media release have been added to the adverse events and Skin Disorders pharmacodynamics and therapeutic trials sections
  • 30 Jan 2006 Phase-II clinical trials in Psoriasis in United Kingdom (Topical, gel)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top